Eric Tam
Overview
Explore the profile of Eric Tam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
802
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muhammad A, Ghazi E, Ali A, Tam E, Woan K, Chaudhary P, et al.
J Med Cases
. 2024 Sep;
15(10):261-266.
PMID: 39328803
Tyrosine kinase inhibitors (TKIs) have changed the prognosis of Philadelphia-positive B-cell acute lymphoblastic leukemia (ALL); however, relapsed and refractory disease after multiple TKIs continues to be a clinical challenge. Brexucabtagene...
2.
Krance S, Hatamnejad A, Uddin R, Somani S, Tam E, Murtaza F, et al.
Can J Ophthalmol
. 2024 Sep;
PMID: 39245292
Objective: To quantify post-cataract surgery health care utilization caused by dry eye symptoms (DES) and identify preoperative risk factors and mediators of postoperative DES. Setting: An outpatient surgical centre in...
3.
Ashouri K, Fernandez E, Ginosyan A, Feliciano C, Hom B, Rodman J, et al.
Transplant Proc
. 2024 Aug;
56(7):1671-1677.
PMID: 39174390
Background: The use of post-transplant cyclophosphamide (PTCy) is highly effective in preventing graft versus host disease (GVHD) for haploidentical allogeneic hematopoietic stem cell transplantation (allo-HSCT). There is limited data on...
4.
Ashouri K, Chennapan K, Martynova A, Nazaretyan S, Ali A, Ginosyan A, et al.
EJHaem
. 2024 Apr;
5(2):423-427.
PMID: 38633126
No abstract available.
5.
Cai Y, Ali A, Filler E, Bayati R, Toma T, Zaki O, et al.
Front Oncol
. 2024 Feb;
14:1329893.
PMID: 38410106
Graft-versus-host disease (GVHD) is a common complication in patients receiving allogeneic hematopoietic stem cell transplantation (HSCT). GVHD is characterized as either acute or chronic based on symptomatology and histopathological findings....
6.
Ashouri K, Nittur V, Ginosyan A, Hwang J, Adnani B, Chen D, et al.
Clin Lymphoma Myeloma Leuk
. 2023 Dec;
24(3):e59-e66.e2.
PMID: 38061959
Introduction: Detection of measurable residual disease (MRD) in adults with acute lymphoblastic leukemia (ALL) is a vital biomarker in risk prediction and treatment selection. Next-generation sequencing (NGS) offers greater sensitivity...
7.
Nazaretyan S, Ali A, Yaghmour G, Tong A, Castillo V, Rodrigues S, et al.
Respir Med Case Rep
. 2023 Oct;
46:101922.
PMID: 37841284
Background: Sweet Syndrome (SS) is a rare inflammatory skin condition characterized by the sudden appearance of tender, erythematous or violaceous papules, plaques, and nodules typically found on the face, neck,...
8.
Zhu H, Ali A, Woan K, Tam E, Yaghmour G, Flores A, et al.
Cell Transplant
. 2023 Mar;
31:9636897221119734.
PMID: 36927092
A patient with an ultimate diagnosis of human herpesvirus-6 (HHV-6) encephalitis developed central nervous system (CNS) symptoms 13 days after undergoing myeloablative haploidentical allogeneic hematopoietic stem cell transplant (HSCT). Due...
9.
Dwabe S, Hsiao M, Ali A, Rodman J, Savitala-Damerla L, Nazaretyan S, et al.
Transpl Immunol
. 2022 Dec;
76:101769.
PMID: 36464218
Background: Cytomegalovirus (CMV) infection significantly impacts the morbidity and mortality of patients undergoing allogeneic hematopoietic stem cell transplant (HSCT). Despite monitoring and pharmacologic prophylaxis with drugs such as valganciclovir or...
10.